MARCOUXMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MARCOUXMED
Largest movements
- Deferred charges and accrued income +€88,539
up €88,539 (+229.3%), from €38,621 to €127,160
- Cash +€52,285
up €52,285 (+39.6%), from €132,055 to €184,340
mainly Net result for the year (+€222,039) and Current investments (+€30,000)
- Receivables within one year +€30,428
up €30,428 (+237.9%), from €12,791 to €43,218
- Current investments -€30,000
down €30,000 (-21.9%), from €137,000 to €107,000
- Profit (loss) carried forward +€222,039
up €222,039 (+291.1%), from €76,270 to €298,309
- Tax, wage and social debts -€53,689
down €53,689 (-100.0%), from €53,689 to €0
- Provisions -€27,420
down €27,420 (-35.0%), from €78,453 to €51,033
- Provisions -€105,873
down €105,873, from €78,453 to -€27,420
- Financial charges +€70,727
up €70,727 (+2790.9%), from €2,534 to €73,261
- Gross operating margin +€40,202
up €40,202 (+14.2%), from €282,695 to €322,896
- Taxes -€13,792
down €13,792 (-18.7%), from €73,856 to €60,064
- Financial income +€4,980
up €4,980 (+527.0%), from €945 to €5,925
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €323,488 | €464,263 | +€140,774 | +43.5% |
| Fixed assets | 21/28 | €3,022 | €2,545 | -€477 | -15.8% |
| Tangible fixed assets | 22/27 | €2,968 | €2,491 | -€477 | -16.1% |
| Plant, machinery and equipment | 23 | €2,968 | €2,491 | -€477 | -16.1% |
| Financial fixed assets | 28 | €54 | €54 | = | 0.0% |
| Current assets | 29/58 | €320,466 | €461,718 | +€141,252 | +44.1% |
| Amounts receivable within one year | 40/41 | €12,791 | €43,218 | +€30,428 | +237.9% |
| Other amounts receivable | 41 | €12,791 | €43,218 | +€30,428 | +237.9% |
| Current investments | 50/53 | €137,000 | €107,000 | -€30,000 | -21.9% |
| Cash at bank and in hand | 54/58 | €132,055 | €184,340 | +€52,285 | +39.6% |
| Deferred charges and accrued income | 490/1 | €38,621 | €127,160 | +€88,539 | +229.3% |
| Total equity and liabilities | 10/49 | €323,488 | €464,263 | +€140,774 | +43.5% |
| Equity | 10/15 | €188,270 | €410,309 | +€222,039 | +117.9% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €110,000 | €110,000 | = | 0.0% |
| Distributable reserves | 133 | €110,000 | €110,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €76,270 | €298,309 | +€222,039 | +291.1% |
| Provisions and deferred taxes | 16 | €78,453 | €51,033 | -€27,420 | -35.0% |
| Provisions for liabilities and charges | 160/5 | €78,453 | €51,033 | -€27,420 | -35.0% |
| Other liabilities and charges | 164/5 | €78,453 | €51,033 | -€27,420 | -35.0% |
| Amounts payable | 17/49 | €56,766 | €2,921 | -€53,845 | -94.9% |
| Amounts payable within one year | 42/48 | €56,766 | €2,921 | -€53,845 | -94.9% |
| Trade debts | 44 | €3,077 | €2,921 | -€156 | -5.1% |
| Suppliers | 440/4 | €3,077 | €2,921 | -€156 | -5.1% |
| Taxes, remuneration and social security | 45 | €53,689 | €0 | -€53,689 | -100.0% |
| Taxes | 450/3 | €53,689 | €0 | -€53,689 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €477 | €477 | = | 0.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €78,453 | -€27,420 | -€105,873 | |
| Other operating charges | 640/8 | €526 | €400 | -€126 | -24.0% |
| Gross operating margin | 9900 | €282,695 | €322,896 | +€40,202 | +14.2% |
| Operating profit (loss) | 9901 | €203,239 | €349,439 | +€146,201 | +71.9% |
| Financial income | 75/76B | €945 | €5,925 | +€4,980 | +527.0% |
| Recurring financial income | 75 | €945 | €5,925 | +€4,980 | +527.0% |
| Financial charges | 65/66B | €2,534 | €73,261 | +€70,727 | +2790.9% |
| Recurring financial charges | 65 | €2,534 | €73,261 | +€70,727 | +2790.9% |
| Profit (loss) for the period before taxes | 9903 | €201,650 | €282,103 | +€80,454 | +39.9% |
| Income taxes | 67/77 | €73,856 | €60,064 | -€13,792 | -18.7% |
| Profit (loss) for the period | 9904 | €127,794 | €222,039 | +€94,245 | +73.7% |
| Profit (loss) for the period to be appropriated | 9905 | €127,794 | €222,039 | +€94,245 | +73.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.